Authors



Eric M. Marr

Latest:

Revisiting "Right to Try" Legislation

In summer 2016, Pharmacy Times® published an article titled “‘Right to Try’ Legislation: A Developing Legal Issue Related to Medications” that discussed the basics of a popular health policy issue.


Sonya Kremenchugsky, PharmD Candidate

Latest:

Travel Immunization in the Pharmacy: Exploring the Growing Opportunity

US citizens are increasingly traveling to international destinations, with Americans making 38 million visits abroad in 2017. Fortunately, pharmacists are well-placed to assist patients in their travel health needs.


Jocelyn Thomas, PharmD

Latest:

New FDA Actions: UCB's Neupro

The FDA approved Neupro (Rotigotine Transdermal System) for the treatment of Parkinson's disease and restless leg syndrome.


Kristen Crossley, MA, Editor

Latest:

CDC: Many Pre-Pandemic Activities Can Resume for Fully Vaccinated Individuals

The agency also advised that fully vaccinated individuals can resume many activities without wearing a mask or social distancing.


Bruce Kneeland

Latest:

Think Outside the Box for Front-End Profit Opportunities in the Pharmacy

Taking steps to improve front-end sales takes some time and out-of-the-box thinking, but it can prove profitable and improve word-of-mouth recommendations.



David M. Mosen, MPH, PhD

Latest:

A Computerized Asthma Outcomes Measure Is Feasible for Disease Management

The ASTHMA-CAT, an online, patient-based assessment measure, may facilitate asthma care management.


Muralikrishna Tangirala, MS, MPH

Latest:

Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast Cancer

Compared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.



Stephanie S. Holliday, PharmD

Latest:

Hepatitis C Case Study at Prosperity Specialty Pharmacy

Adherence for targeted therapies is even more essential now than it ever has been. This case study of services offered at a specialty pharmacy illustrates the impact of hepatitis C patients.


Jasmina Ivanova, MS

Latest:

Daily Dose and Costs of Therapy With Topical Testosterone Agents

We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.



Glenn Schulman, PharmD, MS, BCPS, BCACP, BCGP

Latest:

Leukemia: Causes, Symptoms, and Treatments

Leukemia is a type of cancer that affects blood cell formation and the lymphatic system. It can be classified by cell type, lymphoid or myeloid, and the rate of progression, acute or chronic.


Simon Murray, MD

Latest:

New Evidence Concerning Safety of ACE Inhibitors, ARBs in COVID-19

There continues to be a debate in the scientific community about the role that angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers play in coronavirus disease 2019 infection.


Jennifer Barrett, Associate Editor

Latest:

Expert Panel Examines Biosimilar Pathway

The FDA does not usually require animalstudies for biosimilars; therefore, the process can move directly to pharmacokinetic and pharmacodynamic studies.



Dave Nellesen, PhD

Latest:

Burden of Autosomal Dominant Polycystic Kidney Disease: Systematic Literature Review

The authors present a review of the literature for autosomal dominant polycystic kidney disease to characterize its impact on patients and healthcare systems.


Daniel J. Elliott, MD, MSCE

Latest:

Factors Associated With Employee Participation in a Value-Based Insurance Design Initiative

We describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.


David Bai, PharmD

Latest:

What Factors Influence Response to Multiple Myeloma Treatment?

Two recent studies analyzed factors that impacted response to therapy in patients with multiple myeloma.


Andy He, PharmD Candidate 2011

Latest:

To Substitute or Not to Substitute: That Is the Question

With generic prescriptions on the rise, every pharmacist needs a through understanding of therapeutic equivalence and the generic approval process.


Brandon Hill, 2016 PharmD Candidate

Latest:

PLEI Perspectives: Flipping Your Idea of Education

The pharmacy profession continues to expand its scope of practice, and some may argue that current PharmD curricula inadequately prepare students for this rapidly growing career.



Claire Solofra, PharmD Candidate

Latest:

Get PrEPared for HIV Prophylaxis

Expansion to adolescents, flexible dosing strategies, innovative delivery models, and long-acting antiretrovirals all help the strategy.


Brian Faley, PharmD, BCPS

Latest:

Liposomal Bupivacaine as a Foundation for Multimodal Analgesia in the Postoperative Setting

A 50-year-old male with a history of benign prostatic hyperplasia, chronic obstructive pulmonary disease, and type 2 diabetes mellitus is admitted for a laparoscopic colectomy. The patient's surgeon requests a pharmacy consultation to develop a multimodal, opioid-sparing pain control regimen.


Peter Hoang, 2016 PharmD Candidate

Latest:

3 Tips for Launching a Peer Mentoring Program

The first days of pharmacy school can be exciting for students because they are embarking on a new chapter of their lives.


Matthew Bailey

Latest:

Geriatric Cancers Present Many Therapeutic Challenges

Pharmacists should develop treatment plans with an active interdisciplinary team and patient involvement.


Matthew Seamon, PharmD, Esq

Latest:

Pharmacists in ACOs Part 3: Chronic Care Management, Chronic Disease State Management, and Transition of Care

After discussing the Basics of Accountable Care Organizations and Medication Therapy Management and Annual Wellness Visit services, the third and last section of the Pharmacists in ACOs series will focus on 3 more integration strategies for pharmacists within the ACO setting, including chronic care management, chronic disease state management, and transitions of care.


Ambree Gober, PharmD candidate

Latest:

Protein S Deficiency

Protein S deficiency is a type of inherited thrombophilia associated with increased risk of venous thromboembolism.


Christine Muglia, MD

Latest:

Alpha-Gal (Mammalian Meat) Allergy: Implications for Pharmacists

Alpha-gal, a mammalian oligosaccharide, has recently been implicated in delayed anaphylaxis reactions to mammalian meat.